Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1

Fig. 2

Tumor response after TACE in the four groups of HCC patients. Group1 = Normal weight HCC patients without HBV infection; Group2 = Normal weight HCC patients combined HBV infection; Group3 = Overweight HCC patients without HBV infection; Group4 = Overweight HCC patients combined HBV infection; CR = Complete response; PR = Partial response; SD=Stable disease; PD=Progressive disease

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us